{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:28:19Z","timestamp":1765546099240},"reference-count":41,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Health Research Doctoral Research Fellowship"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.vaccine.2016.06.038","type":"journal-article","created":{"date-parts":[[2016,6,26]],"date-time":"2016-06-26T02:26:20Z","timestamp":1466907980000},"page":"3986-3992","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The impact of administration of conjugate vaccines containing cross reacting material on Haemophilus influenzae type b antibody responses in infants: A systematic review and meta-analysis of randomised controlled trials"],"prefix":"10.1016","volume":"34","author":[{"given":"Merryn","family":"Voysey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Sadarangani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Clutterbuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Bolgiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.06.038_b0005","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/adc.86.6.396","article-title":"The UK Hib vaccine experience","volume":"86","author":"Heath","year":"2002","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2016.06.038_b0010","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.06.038_b0015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1473-3099(14)70027-1","article-title":"Hospital admission rates for meningitis and septicaemia caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study","volume":"14","author":"Martin","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2016.06.038_b0020","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1016\/j.vaccine.2011.04.053","article-title":"Comparative effects of carrier proteins on vaccine-induced immune response","volume":"29","author":"Knuf","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.038_b0025","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.4161\/hv.26109","article-title":"Protein carriers of conjugate vaccines: characteristics, development, and clinical trials","volume":"9","author":"Pichichero","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2016.06.038_b0030","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.vaccine.2009.01.005","article-title":"The influence of carrier protein on the immunogenicity of simultaneously administered conjugate vaccines in infants","volume":"27","author":"Pollabauer","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.038_b0035","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jpeds.2008.04.032","article-title":"Blame vaccine interference, not neonatal immunization, for suboptimal responses after neonatal diphtheria, tetanus, and acellular pertussis immunization","volume":"153","author":"Siegrist","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2016.06.038_b0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/adc.2005.076109","article-title":"Evaluation of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b vaccine given concurrently with meningococcal group C conjugate vaccine at 2, 3 and 4 months of age","volume":"92","author":"Kitchin","year":"2007","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2016.06.038_b0045","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1586\/erv.11.142","article-title":"Glycoconjugate vaccines and immune interactions, and implications for vaccination schedules","volume":"10","author":"Borrow","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.06.038_b0050","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1016\/j.vaccine.2010.06.026","article-title":"Glycoconjugate vaccines and immune interference: a review","volume":"28","author":"Dagan","year":"2010","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2016.06.038_b0055","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/21645515.2015.1091908","article-title":"Interactions of conjugate vaccines and co-administered vaccines","volume":"12","author":"Findlow","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2016.06.038_b0060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/INF.0000000000000930","article-title":"Safety and immunogenicity of a quadrivalent meningococcal conjugate vaccine and commonly administered vaccines after co-administration","volume":"35","author":"Gasparini","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.06.038_b0065","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/bmj.315.7119.1371","article-title":"Meta-Analysis. Potentials and promise","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2016.06.038_b0070","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/1536867X1001000307","article-title":"Metaan: random-effects meta-analysis","volume":"10","author":"Kontopantelis","year":"2010","journal-title":"Stata J"},{"key":"10.1016\/j.vaccine.2016.06.038_b0075","doi-asserted-by":"crossref","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.06.038_b0080","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Res Synth Meth"},{"key":"10.1016\/j.vaccine.2016.06.038_b0085","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2016.06.038_b0090","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2016.06.038_b0095","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/01.inf.0000227725.61495.c4","volume":"25","author":"Tejedor","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.06.038_b0100","series-title":"34th annual meeting of the european society for paediatric infectious diseases","article-title":"Antibody responses against Haemophilus influenzae type b with administration of different capsular group C meningococcal conjugate vaccines: an open-label randomised controlled trial","author":"Voysey","year":"2016"},{"key":"10.1016\/j.vaccine.2016.06.038_b0105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jama.2007.29-c","article-title":"Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial","volume":"299","author":"Snape","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2016.06.038_b0110","unstructured":"GlaxoSmithKline Clinical Study Register. Study 113369; 2016. <http:\/\/wwwgskclinicalstudyregistercom\/study\/113369#ps>."},{"key":"10.1016\/j.vaccine.2016.06.038_b0115","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4161\/hv.3.5.4352","article-title":"A retrospective study on the quality of Haemophilus influenzae type b vaccines used in the UK between 1996 and 2004","volume":"3","author":"Bolgiano","year":"2007","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2016.06.038_b0120","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.vaccine.2015.01.046","article-title":"Structural correlates of carrier protein recognition in tetanus toxoid-conjugated bacterial polysaccharide vaccines","volume":"33","author":"Lockyer","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.038_b0125","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1097\/INF.0b013e318199f61b","article-title":"Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV)","volume":"28","author":"Knuf","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.06.038_b0130","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1128\/IAI.66.5.2093-2098.1998","article-title":"Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants","volume":"66","author":"Dagan","year":"1998","journal-title":"Inf Immun"},{"key":"10.1016\/j.vaccine.2016.06.038_b0135","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/CVI.00420-08","article-title":"Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom","volume":"16","author":"Southern","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2016.06.038_b0140","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1128\/CVI.00377-06","article-title":"Immunogenicity, reactogenicity, and immune memory after primary vaccination with a novel Haemophilus influenzae-Neisseria meningitidis serogroup C conjugate vaccine","volume":"14","author":"Schmitt","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2016.06.038_b0145","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4161\/hv.27051","article-title":"Immunogenicity and safety of a CRM-conjugated meningococcal ACWY vaccine administered concomitantly with routine vaccines starting at 2 months of age","volume":"10","author":"Nolan","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2016.06.038_b0150","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/INF.0b013e31823dce5c","article-title":"Safety and immunogenicity of a novel quadrivalent meningococcal CRM-conjugate vaccine given concomitantly with routine vaccinations in infants","volume":"31","author":"Klein","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.06.038_b0155","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijid.2014.03.1390","article-title":"Immunogenicity and safety of a quadrivalent meningococcal polysaccharide CRM conjugate vaccine in infants and toddlers","volume":"26","author":"Tregnaghi","year":"2014","journal-title":"Int J Inf Dis"},{"key":"10.1016\/j.vaccine.2016.06.038_b0160","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1016\/j.vaccine.2006.03.032","article-title":"Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV\/Hib combination vaccine in healthy infants","volume":"24","author":"Knuf","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.038_b0165","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.inf.0000148923.46453.48","article-title":"Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate Vaccine","volume":"24","author":"Tichmann-Schumann","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.06.038_b0170","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1016\/j.vaccine.2011.06.026","volume":"29","author":"Gimenez-Sanchez","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.038_b0175","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1097\/INF.0b013e3181faa6be","article-title":"Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial","volume":"29","author":"Snape","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.06.038_b0180","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1128\/CVI.00062-10","article-title":"Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers","volume":"17","author":"Esposito","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2016.06.038_b0185","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4161\/hv.7.5.14634","article-title":"Safety and immunogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Chilean children","volume":"7","author":"Lagos","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2016.06.038_b0190","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1186\/1471-2458-11-882","article-title":"Primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in infants in Mali and Nigeria: a randomized controlled trial","volume":"11","author":"Dicko","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2016.06.038_b0195","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1097\/INF.0b013e31822a8541","article-title":"Response to primary and booster vaccination with 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine in Korean infants","volume":"30","author":"Kim","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.06.038_b0200","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/INF.0b013e3182323ac2","article-title":"Induction of immunologic memory following primary vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine in infants","volume":"31","author":"Knuf","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.06.038_b0205","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1097\/INF.0b013e31821a0614","volume":"30","author":"van den Bergh","year":"2011","journal-title":"Pediatr Infect Dis J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16304625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16304625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T05:24:04Z","timestamp":1656739444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16304625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":41,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0264410X16304625"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.06.038","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of administration of conjugate vaccines containing cross reacting material on Haemophilus influenzae type b antibody responses in infants: A systematic review and meta-analysis of randomised controlled trials","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.06.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}